GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Schedule of meet
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals has informed the stock exchanges about a scheduled group meeting with analysts and institutional investors on 1st August 2025. The meeting will be held digitally, and only information already available in the public domain will be shared during the interaction. The disclosure has been made under SEBI Listing Regulations (Regulation 30), and the company has noted that the date is subject to change due to unforeseen reasons.
This is a routine compliance filing with no new material information. Investors should not expect any fresh disclosures from this meeting, and it is unlikely to have any impact on the stock price.